IL1B and cystic fibrosis: Treatment with LPS and IL-1β/TNFα showed a statistically significant increase in mRNA IGFBP-6 expression in both CF and non-CF nasal epithelial cultures and was reduced by DMF co-treatment (Figure 4B).